Emanuele Cencini

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 25

Top Venues

Hematological oncology

Annals of hematology

European journal of haematology

Hematology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Vittorio Ruggero Zilioli, Emanuele Cencini, Sonya De Lorenzo, Luca Pezzullo, Michele Merli, Flavia Rivellini, Cristina Muzi, Barbieri Emiliano, Luigi Marcheselli, Stefano Luminari
Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience. Hematological oncology 42 (3) (2024)
Vittorio Ruggero Zilioli, Emanuele Cencini, Sonya De Lorenzo, Luca Pezzullo, Michele Merli, Flavia Rivellini, Cristina Muzi, Barbieri Emiliano, Luigi Marcheselli, Stefano Luminari
Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience. Hematological oncology 42 (3) (2024)
Emanuele Cencini, Natale Calomino, Marta Franceschini, Andreea Dragomir, Sara Fredducci, Beatrice Esposito Vangone, Giulia Lucco Navei, Alberto Fabbri, Monica Bocchia
Survival Outcomes of Patients with Mantle Cell Lymphoma: A Retrospective, 15-Year, Real-Life Study. Hematology reports 16 (1) (2024)
Emanuele Cencini, Natale Calomino, Marta Franceschini, Andreea Dragomir, Sara Fredducci, Beatrice Esposito Vangone, Giulia Lucco Navei, Alberto Fabbri, Monica Bocchia
Survival Outcomes of Patients with Mantle Cell Lymphoma: A Retrospective, 15-Year, Real-Life Study. Hematology reports 16 (1) (2024)
Vittorio Ruggero Zilioli, Emanuele Cencini, Sonya De Lorenzo, Luca Pezzullo, Michele Merli, Flavia Rivellini, Cristina Muzi, Barbieri Emiliano, Luigi Marcheselli, Stefano Luminari
Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience. Hematological oncology 42 (3) (2024)
Emanuele Cencini, Natale Calomino, Marta Franceschini, Andreea Dragomir, Sara Fredducci, Beatrice Esposito Vangone, Giulia Lucco Navei, Alberto Fabbri, Monica Bocchia
Survival Outcomes of Patients with Mantle Cell Lymphoma: A Retrospective, 15-Year, Real-Life Study. Hematology reports 16 (1) (2024)
Emanuele Cencini, Ilaria Romano, Francesco Ghio, Chiara Camerini, Ilaria Bertaggia, Roberta Giachetti, Lara Mannelli, Maria Teresa Pirrotta, Giulia Lucco Navei, Manuel Ciceri, Giulia Cervetti, Emanuela Sant'Antonio, Federico Simonetti, Silvia Birtolo, Benedetta Puccini, Monica Bocchia, Alberto Fabbri
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network). Annals of hematology 102 (4) (2023)
Emanuele Cencini, Ilaria Romano, Francesco Ghio, Chiara Camerini, Ilaria Bertaggia, Roberta Giachetti, Lara Mannelli, Maria Teresa Pirrotta, Giulia Lucco Navei, Manuel Ciceri, Giulia Cervetti, Emanuela Sant'Antonio, Federico Simonetti, Silvia Birtolo, Benedetta Puccini, Monica Bocchia, Alberto Fabbri
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network). Annals of hematology (2023)
Emanuele Cencini, Anna Sicuranza, Sara Ciofini, Alberto Fabbri, Monica Bocchia, Alessandro Gozzetti
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications. Current oncology (Toronto, Ont.) 30 (7) (2023)
Emanuele Cencini, Ilaria Romano, Francesco Ghio, Chiara Camerini, Ilaria Bertaggia, Roberta Giachetti, Lara Mannelli, Maria Teresa Pirrotta, Giulia Lucco Navei, Manuel Ciceri, Giulia Cervetti, Emanuela Sant'Antonio, Federico Simonetti, Silvia Birtolo, Benedetta Puccini, Monica Bocchia, Alberto Fabbri
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network). Annals of hematology 102 (4) (2023)
Emanuele Cencini, Ilaria Romano, Francesco Ghio, Chiara Camerini, Ilaria Bertaggia, Roberta Giachetti, Lara Mannelli, Maria Teresa Pirrotta, Giulia Lucco Navei, Manuel Ciceri, Giulia Cervetti, Emanuela Sant'Antonio, Federico Simonetti, Silvia Birtolo, Benedetta Puccini, Monica Bocchia, Alberto Fabbri
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network). Annals of hematology 102 (4) (2023)
Martina D'Onghia, Alessandra Cartocci, Laura Calabrese, Daniele Maio, Azzurra Sirchio, Maria Erasti, Linda Tognetti, Pietro Rubegni, Monica Bocchia, Emanuele Cencini, Alberto Fabbri, Elisa Cinotti
Characteristics of Primary Cutaneous Lymphoma in Italy: A Tertiary Care, Single-Center Study. Current oncology (Toronto, Ont.) 30 (11) (2023)
Emanuele Cencini, Melania Rocco, Francesco Ghio, Federico Simonetti, Annarosa Cuccaro, Federica De Marco, Chiara Consoli, Monica Bocchia, Alberto Fabbri
Long-term efficacy in patients with relapsed/refractory diffuse large B-cell lymphoma achieving a complete response with pixantrone. European journal of haematology (2023)
Emanuele Cencini, Alberto Fabbri
Pixantrone in patients with relapsed/refractory diffuse large B-cell lymphoma: A real-life, retrospective, multicenter trial on behalf of the "RTL" (Regional TUSCAN Lymphoma Network)-Authors' reply to Morris and colleagues. European journal of haematology 109 (5) (2022)
Emanuele Cencini, Bianca Mecacci, Melania Rocco, Fabio Innocenti, Francesco Ghio, Benedetta Puccini, Roberta Della Seta, Federico Simonetti, Lara Mannelli, Annarosa Cuccaro, Monica Bocchia, Alberto Fabbri
Pixantrone in patients with relapsed/refractory diffuse large B-cell lymphoma: A real-life, retrospective, multicenter trial on behalf of the "RTL" (Regional Tuscan Lymphoma network). European journal of haematology 108 (5) (2022)
Emanuele Cencini, Alessandra Tucci, Benedetta Puccini, Federica Cavallo, Stefano Luminari, Sara Veronica Usai, Alberto Fabbri, Elsa Pennese, Dario Marino, Vittorio Ruggero Zilioli, Monica Balzarotti, Luigi Petrucci, Agostino Tafuri, Annalisa Arcari, Barbara Botto, Manuela Zanni, Stefan Hohaus, Roberto Sartori, Michele Merli, Guido Gini, Wael Al Essa, Gerardo Musurca, Monica Tani, Luca Nassi, Rosa Daffini, Caterina Mammi, Luigi Marcheselli, Monica Bocchia, Michele Spina, Francesco Merli
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi. Hematological oncology (2022)
Francesco Merli, Stefano Luminari, Alessandra Tucci, Annalisa Arcari, Luigi Rigacci, Eliza A Hawkes, Carlos Sérgio Chiattone, Federica Cavallo, Giuseppina Cabras, Isabel Alvarez, Alberto Fabbri, Alessandro Re, Benedetta Puccini, Allison Barraclough, Márcia Torresan Delamain, Simone Ferrero, Sara Veronica Usai, Angela Ferrari, Emanuele Cencini, Elsa Pennese, Vittorio Ruggero Zilioli, Dario Marino, Monica Balzarotti, Maria Christina Cox, Manuela Zanni, Alice Di Rocco, Arben Lleshi, Barbara Botto, Stefan Hohaus, Michele Merli, Roberto Sartori, Guido Gini, Luca Nassi, Gerardo Musuraca, Monica Tani, Chiara Bottelli, Sofia Kovalchuk, Francesca Re, Leonardo Flenghi, Annalia Molinari, Giuseppe Tarantini, Emanuela Chimienti, Luigi Marcheselli, Caterina Mammi, Michele Spina
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (11) (2021)
Elisabetta Zappone, Emanuele Cencini, Marzia Defina, Anna Sicuranza, Alessandro Gozzetti, Sara Ciofini, Donatella Raspadori, Bianca Mecacci, Monica Bocchia
Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T-cell lymphoblastic leukemia. Clinical case reports 8 (10) (2020)
Michele Merli, Dario Marino, Emanuele Cencini, Sara Rattotti, Costanza Fraenza, Paolo Grossi, Benedetta Bianchi, Barbara Mora, Roberta Sciarra, Silvia Finotto, Bianca Mecacci, Francesco Passamonti, Carlo Visco, Luca Arcaini
Direct-acting antivirals in hepatitis C virus-positive mantle cell lymphomas. Hematological oncology 39 (2) (2020)
Michele Merli, Stefano Luminari, Lucia Farina, Federica Cocito, Irene Defrancesco, Guido Gini, Annalisa Arcari, Greta Scapinello, Massimo Gentile, Maria Goldaniga, Giacomo Loseto, Emanuele Cencini, Antonino Greco, Anna Lia Molinari, Andrea Ferrario, Benedetta Bianchi, Barbara Mora, Lorenza Bertù, Vincenzo Saturni, Fabio Bergamini, Nicole Fabbri, Francesca Gaia Rossi, Silvia Bolis, Francesco Passamonti, Luca Arcaini
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi. Bone marrow transplantation 55 (12) (2020)
Emanuele Cencini, Alberto Fabbri, Adele Santoni, Bianca Mecacci, Monica Bocchia
Coexistence of Serum Monoclonal Gammopathy of Uncertain Significance and Hodgkin Lymphoma. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 36 (2) (2019)
Emanuele Cencini, Alberto Fabbri, Anna Sicuranza, Adele Santoni, Monica Bocchia
Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience. Hematological oncology 37 (4) (2019)
Emanuele Cencini, Anna Sicuranza, Alberto Fabbri, Ilaria Ferrigno, Luigi Rigacci, Maria Christina Cox, Donatella Raspadori, Monica Bocchia
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab. British journal of haematology 184 (2) (2018)
Emanuele Cencini, Alberto Fabbri, Francesco Lauria, Monica Bocchia
Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review. Annals of hematology 97 (5) (2018)
Emanuele Cencini, Alberto Fabbri, Monica Bocchia
Prognostic role of M2 tumour-associated macrophages in lymphoproliferative disorders. The Journal of pathology 242 (4) (2017)

Emanuele Cencini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Emanuele Cencini